| Project/Area Number |
18591377
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Chiba University |
|---|
Principal Investigator |
KAWATA Tetsuya Chiba University, Graduate School of Med., Associate Professor (60234077)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ITO Hisao Chiba University, Graduate School of Med, Professor (20095574)
UNO Takashi Chiba University, Graduate School of Med, Associate Prof (30302540)
ISOBE Koichi Chiba University, Hospital, Associate Prof (80334184)
|
|---|
| Project Period (FY) |
2006 – 2007
|
| Project Status |
Completed (Fiscal Year 2007)
|
| Budget Amount *help |
¥3,950,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2007: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2006: ¥2,000,000 (Direct Cost: ¥2,000,000)
|
|---|
| Keywords | hypoxic cells / siRNA / radiation damage / Ku80 / 低酸素 / 放射線感受性 / DAN修復 / 静止期細胞 |
|---|
| Research Abstract |
It is known that in tumors there are some fraction of hypoxic cells and these cells are resistant to radiation. These cells are also known as quiescent cells which cell cycle belongs to G0. We have measured the cell sensitivity under hypoxic and normal oxic condition. It was found that when cells are allowed to repair for several hours under each condition, cell survival was almost the same, suggesting that hypoxic cells can repair dsbs as efficiency as normal oxic cells. To enhance radiation effect, we employed Ku80 siRNA for mice (Balb/c) tumors, which were transplanted before experiment, and found that tumor growth was suppressed by using it. However, when mice tumors were injected with Ku80 siRNA under hypoxic condition by expulsion of blood flow, no significant difference was observed compared to normal oxic condition. This result suggests that Ku80 siRNA itself is not effective to hypoxic quiescent cells. Further experiments are underway using other NHEJ (non homologous end joining) inhibitors to enhance tumor radiosensitivity since most quiescent cells repair dsbs using NHEJ repair process.
|
